Delphinus Medical Technologies announced today that it received FDA premarket approval (PMA) for its SoftVue system. Novi, Michigan-based Delphinus develops the SoftVue 3D whole breast ultrasound tomography system for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue, according to a news release. The company said SoftVue […]
Delphinus Medical Technologies Inc.
From BrainScope’s pediatric traumatic brain injury assessment device to EOS Imaging releasing new surgery planning software, here are seven medtech stories we missed this week but thought were still worth a mention. 1. BrainScope to develop pediatric traumatic brain injury assessment device BrainScope announced in a Sept. 7 press release that it will immediately start creating […]
Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]
Delphinus Medical Technologies has raised $8.2 million in a new mixed-shelf offering, according to an SEC filing posted this week. The Novi, Mich.-based company is looking for an additional $16.8 million in the round, for a total of $25 million, and has not yet said how it plans to spend funds raised in the round. Delphinus produces […]
MannKind Corporation said last week it picked up ex-Insulet (NSDQ:PODD) CEO Duane DeSisto as its new prez and CEO, effective January 5, 2016. DeSisto will replace interim CEO Alfred Mann, who has held the spot since November. DeSisto will also join the company’s board of directors, according to a press release from the Valencia, Calif.-based company. […]
Cardiac Dimensions said this week that it tapped the former chief of AccessClosure, Gregory Casciaro, to be its new president & CEO. Casciaro led AccessClosure until its May 2014 acquisition by Cardinal Health (NYSE:CAH) for $320 million. His résumé includes stints as the chief executive at drug-eluting stent maker Xtent, Orquest (acquired JNJ’s DePuy Acromed in 2003) […]
Delphinus Medical Technologies Inc. received $8 million in funding commitments to further develop an ultrasonic breast cancer detection device that could become an alternative to mammograms.
The funding means that Delphinus can finally begin the process of commercializing its SoftVue device, which has undergone about 10 years of research and development.